All data are based on the daily closing price as of June 6, 2025
s

Sam Chun Dang Pharm

000250.KQ
111.89 USD
5.56
+5.23%

Overview

Last close
111.89 usd
Market cap
2.40B usd
52 week high
154.63 usd
52 week low
46.93 usd
Target price
45.62 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
16.4346
Price/Book Value
13.4991
Enterprise Value
2.55B usd
EV/Revenue
16.2377
EV/EBITDA
177.3037

Key financials

Revenue TTM
129.87M usd
Gross Profit TTM
60.94M usd
EBITDA TTM
13.05M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
335.06M usd
Net debt
N/A usd

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
  • Symbol
    000250.KQ
  • Exchange
    KQ
  • Isin
    KR7000250001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Dae-In Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.scd.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top